A fast-growing biotechnology company sought to commercialize an advanced proteomic analysis platform capable of delivering precise, multiplexed data through a streamlined sample-to-data workflow. The company needed a development partner that could rapidly engineer a functional prototype, integrate highly complex subsystems into a compact architecture, and position the platform for scalable manufacturing. Ascential engineered and refined the system from prototype through beta development, integrating sophisticated optics, fluidics, motion control, thermal management, and embedded controls into a compact, user-friendly instrument designed for future commercialization.
The client had developed an innovative concept for high-throughput multiplex proteomic analysis but required an engineering and manufacturing partner capable of transforming the vision into a functional, scalable platform. The system needed to integrate sophisticated optics, fluidics, and motion systems into a compact, user-friendly device while maintaining cost-effectiveness and manufacturability for future production scale-up.
In addition to the technical complexity, the program operated under an aggressive development timeline. A working prototype needed to be completed quickly to support investor demonstrations and secure additional funding. The platform also needed to establish a foundation for future commercialization, including scalability and serviceability. The client’s objectives included:
Develop a functional alpha prototype within a compressed timeline to engage investors and secure funding.
Integrate advanced optics, fluidics, motion control, and thermal management systems into a streamlined instrument architecture.
Ensure the platform could transition efficiently from prototype to scalable production through Design for Manufacturability principles and cost optimization.
Create a system that satisfied both aesthetic and functional requirements, including field-replaceable units (FRUs) for future serviceability.
Ascential partnered closely with the client to rapidly engineer and refine the platform from concept through beta development. The engagement began with accelerated prototype development, resulting in delivery of a functional alpha system in just 12 weeks. This enabled the client to demonstrate the feasibility and potential of the technology to investors and stakeholders.
Following alpha delivery, Ascential refined the platform architecture during beta development, integrating motion control, fluidics, and temperature management systems into a compact and serviceable enclosure. The engineering team collaborated closely with the client’s industrial design group to ensure the final system met both functional and aesthetic requirements.
Ascential also integrated firmware with the client’s front-end software to enable seamless system operation and user interaction. In parallel, the team evaluated scalability and production optimization opportunities, including component analysis for future cost reduction and higher-volume manufacturing strategies.
The resulting platform supports high-throughput proteomic analysis through an automated sample-to-data workflow. Users can insert samples, configure analytes without predefined antibody panel limitations, and initiate automated processing through a streamlined interface. The platform generates quantified multiplex proteomic data across all processed samples.
The system incorporated a sophisticated combination of automation, controls, and analytical technologies engineered by Ascential’s cross-functional development team.
| Capability | What Ascential Built |
|---|---|
| Automated Workflow | Automated sample-to-data workflow with user-selectable analyte configuration |
| Multiplex Proteomic Analysis | High-multiplex capability with quantified proteomic data generation across processed samples |
| Protein Capture Technology | Integrated 3-D Nanoscale Protein Capture (3D-NPC) technology with covalent protein immobilization in a rigid nanoporous matrix |
| Signal Generation | Rapid, repeatable antibody–protein binding kinetics enabling precise signal generation |
| System Integration | Integrated motion control, fluidics, thermal management, and embedded controls into a compact instrument architecture |
| Firmware & Controls | Custom in-house control boards with integrated firmware and front-end software connectivity |
| Design for Manufacturability | Evaluated scalability, serviceability, and future cost optimization for higher-volume production |
Ascential successfully delivered the alpha prototype within the aggressive 12-week development timeline, enabling the client to demonstrate the platform and secure additional funding.
The beta system was delivered on time and within budget while meeting all required performance criteria. By the conclusion of the engagement, the client had a high-quality, market-ready instrument architecture positioned for future scalable production.
Key outcomes included:
Bringing advanced life sciences instrumentation to market requires more than innovative technology. It requires the ability to rapidly integrate complex subsystems, engineer for manufacturability, and maintain development velocity under demanding commercial timelines.
For this client, the platform established a scalable foundation for high-throughput multiplex proteomic analysis while demonstrating technical feasibility to investors and stakeholders. By combining rapid prototyping, integrated engineering, and manufacturing-focused design principles, Ascential helped position the platform for future commercialization and production scale-up.
The engagement also highlights Ascential’s ability to execute highly complex life sciences development programs under compressed timelines while balancing technical performance, usability, and manufacturability.
From rapid prototyping to scalable manufacturing, Ascential helps life sciences innovators accelerate commercialization of sophisticated systems and instruments.
Get Your 15-Minute Consultation
